Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
new york blog main
2
×
texas blog main
2
×
texas top stories
3m
ace
acelity
acquisition
allergan
apax partners
arena pharmaceuticals
biotech
boston blog main
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
breast implant
breast reconstruction
buyout
cancer
cardiovascular disease
chase pharmaceutical corp.
china
clinical trials
colorectal cancer
debt
detroit blog main
detroit top stories
eisai
electronics
employment
energy
europe blog main
europe top stories
exome
fda
fired
What
post
2
×
ace
acelity
acquired
antonio
bandages
billion
cancer
deal
drug
eisai
ending
fda
flags
higher
incidence
ipo
lorcaserin
loss
maker
market
marketing
medicine
patients
plan
products
pulls
risks
san
sells
study
took
valued
weeks
weight
withdrawing
Language
unset
Current search:
post
×
" texas blog main "
×
" new york blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan